Addus HomeCare (ADUS)
(Real Time Quote from BATS)
$82.38 USD
-0.90 (-1.08%)
Updated Jul 1, 2022 10:22 AM ET
3-Hold of 5 3
B Value C Growth C Momentum C VGM
Income Statements
Fiscal Year end for Addus HomeCare Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/21 | 12/31/20 | 12/31/19 | 12/31/18 | 12/31/17 | |
---|---|---|---|---|---|
Sales | 865 | 765 | 649 | 518 | 426 |
Cost Of Goods | 595 | 539 | 470 | 380 | 310 |
Gross Profit | 270 | 226 | 179 | 138 | 116 |
Selling & Adminstrative & Depr. & Amort Expenses | 204 | 182 | 144 | 114 | 89 |
Income After Depreciation & Amortization | 66 | 45 | 35 | 24 | 26 |
Non-Operating Income | 0 | 1 | 2 | 3 | 0 |
Interest Expense | 6 | 3 | 3 | 5 | 4 |
Pretax Income | 60 | 42 | 33 | 22 | 22 |
Income Taxes | 15 | 9 | 7 | 5 | 9 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 45 | 33 | 26 | 17 | 13 |
Extras & Discontinued Operations | 0 | 0 | -1 | 0 | 0 |
Net Income | 45 | 33 | 25 | 18 | 14 |
Depreciation Footnote | 12/31/21 | 12/31/20 | 12/31/19 | 12/31/18 | 12/31/17 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 81 | 57 | 46 | 34 | 35 |
Depreciation & Amortization (Cash Flow) | 15 | 13 | 11 | 9 | 9 |
Income After Depreciation & Amortization | 66 | 45 | 35 | 24 | 26 |
Earnings Per Share Data | 12/31/21 | 12/31/20 | 12/31/19 | 12/31/18 | 12/31/17 |
---|---|---|---|---|---|
Average Shares | 16.06 | 15.96 | NA | 12.38 | 11.62 |
Diluted EPS Before Non-Recurring Items | 3.19 | 2.79 | NA | 1.69 | 1.45 |
Diluted Net EPS | 2.81 | 2.08 | 1.77 | 1.41 | 1.17 |
Fiscal Year end for Addus HomeCare Corporation falls in the month of December .
All items in Millions except EPS data.
6/30/22 | 3/31/22 | 12/31/21 | 9/30/21 | 6/30/21 | |
---|---|---|---|---|---|
Sales | 226.63 | 224.64 | 216.66 | 217.89 | 205.30 |
Cost Of Goods | 156.45 | 151.85 | 149.62 | 149.08 | 144.11 |
Gross Profit | 70.19 | 72.80 | 67.05 | 68.81 | 61.20 |
SG&A, R&D, and Dept/Amort Expenses | 56.67 | 53.44 | 49.69 | 51.77 | 49.03 |
Income After SG&A, R&D, and Dept/Amort Expenses | 13.52 | 19.36 | 17.36 | 17.04 | 12.17 |
Non-Operating Income | 0.06 | 0.18 | 0.04 | 0.03 | 0.02 |
Interest Expense | 1.82 | 1.71 | 1.61 | 1.26 | 1.22 |
Pretax Income | 11.75 | 17.82 | 15.78 | 15.82 | 10.98 |
Income Taxes | 3.28 | 4.76 | 4.21 | 4.22 | 2.08 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 8.47 | 13.06 | 11.58 | 11.60 | 8.89 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income | 8.47 | 13.06 | 11.58 | 11.60 | 8.89 |
Earnings Per Share Data | 6/30/22 | 3/31/22 | 12/31/21 | 9/30/21 | 6/30/21 |
---|---|---|---|---|---|
Average Shares | 16.08 | 16.06 | 16.03 | 16.04 | 16.07 |
Diluted EPS Before Non-Recurring Items | 0.66 | 0.86 | 0.80 | 0.78 | 0.62 |
Diluted Net EPS | 0.53 | 0.82 | 0.72 | 0.72 | 0.55 |